Liraglutide in Spinal Fluid

Not Applicable

Completed

• Conditions: Liraglutide Blood-brain Transfer
• Interventions: Procedure: Lumbar puncture

• Registration Number: NCT02104037
• Lead Sponsor: Mikkel Christensen

Brief Summary

The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01
• Primary Completion: 2013-12
• Status Verified: 2014-04
• Study First Submitted: 2014-04-01
• Study First Submitted QC: 2014-04-03
• Last Update Submitted: 2014-04-03
• Study First Posted: 2014-04-04
• Last Update Posted: 2014-04-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Liraglutide treated patients	Lumbar puncture	-

Primary Outcome Measures

Name	Time	Method
cerebrospinal fluid concentration of liraglutide	time 60 minutes

Trial Locations

Locations (1)

Diabetes Research Division, Department of Medicine; 🇩🇰 Hellerup, Denmark